Investor Overview
We believe in a digitally empowered future for clinicians and researchers, with live microscopic imaging playing an important role in establishing a new standard of precision healthcare. We believe our patent-protected technology will help clinicians make immediate informed decisions that provide economic efficiencies within health systems and improve patient outcomes.
Optiscan is a global medical technology company leading the transformation of digital pathology and precision surgery.
We have developed cutting edge technology that delivers:
- Real-time, non-invasive, point-of-care microscopic imaging
- Biopsy-free, slide-free, live single-cell imaging
- Immediate clinical feedback and surgical workflow
- Unlimited sampling across diseased tissue
- Clinician and pathologist collaboration via digital workflow
Through this, we are able to dramatically improve medical outcomes through:
- Immediate, informed clinical decisions and collaboration
- Improved patient outcomes with clearly defined, targeted cancer screening and surgical margin assessment
- Digital equivalent to standard pathology
- Near perfect concordance with frozen section biopsy
- Efficiencies within healthcare systems through reduced need for traditional histopathology and revision surgery
“We believe in a digitally empowered future for clinicians and researchers, with live microscopic imaging playing an important role in establishing a new standard of precision healthcare. We believe our patent-protected technology will help clinicians make immediate informed decisions that provide economic efficiencies within health systems and improve patient outcomes.”
Learn more
